These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

566 related articles for article (PubMed ID: 15280569)

  • 21. A novel missense mutation in tumour necrosis factor receptor superfamily 1A (TNFRSF1A) gene found in tumour necrosis factor receptor-associated periodic syndrome (TRAPS) manifesting adult-onset Still disease-like skin eruptions: report of a case and review of the Japanese patients.
    Nakamura M; Kobayashi M; Tokura Y
    Br J Dermatol; 2009 Oct; 161(4):968-70. PubMed ID: 19673872
    [No Abstract]   [Full Text] [Related]  

  • 22. No association of polymorphisms in the tumor necrosis factor receptor I and receptor II genes with disease severity in rheumatoid arthritis.
    Glossop JR; Nixon NB; Dawes PT; Hassell AB; Mattey DL
    J Rheumatol; 2003 Jul; 30(7):1406-9. PubMed ID: 12858434
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel markers of inflammation identified in tumor necrosis factor receptor-associated periodic syndrome (TRAPS) by transcriptomic analysis of effects of TRAPS-associated tumor necrosis factor receptor type I mutations in an endothelial cell line.
    Rebelo SL; Amel-Kashipaz MR; Radford PM; Bainbridge SE; Fiets R; Fang J; McDermott EM; Powell RJ; Todd I; Tighe PJ
    Arthritis Rheum; 2009 Jan; 60(1):269-80. PubMed ID: 19116900
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differences in tumor necrosis factor-alpha soluble receptor serum concentrations between patients with Henoch-Schönlein purpura and pediatric systemic lupus erythematosus: pathogenetic implications.
    Gattorno M; Picco P; Barbano G; Stalla F; Sormani MP; Buoncompagni A; Gusmano R; Borrone C; Pistoia V
    J Rheumatol; 1998 Feb; 25(2):361-5. PubMed ID: 9489835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A Dutch family with the hereditary periodic fever or tumour necrosis factor receptor-associated periodic syndrome (TRAPS)].
    Chang Pan Huo NM; Dankert-Roelse JE; Kwee ML
    Ned Tijdschr Geneeskd; 2006 Dec; 150(49):2711-4. PubMed ID: 17194009
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutant forms of tumour necrosis factor receptor I that occur in TNF-receptor-associated periodic syndrome retain signalling functions but show abnormal behaviour.
    Todd I; Radford PM; Draper-Morgan KA; McIntosh R; Bainbridge S; Dickinson P; Jamhawi L; Sansaridis M; Huggins ML; Tighe PJ; Powell RJ
    Immunology; 2004 Sep; 113(1):65-79. PubMed ID: 15312137
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel missense mutation in tumour necrosis factor receptor superfamily 1A (TNFRSF1A) gene found in tumour necrosis factor receptor-associated periodic syndrome (TRAPS) with high serum interleukin (IL)-22.
    Nakamura M; Tokura Y
    Eur J Dermatol; 2010; 20(4):508-9. PubMed ID: 20400394
    [No Abstract]   [Full Text] [Related]  

  • 28. Circulating levels of tumor necrosis factor soluble receptors in systemic lupus erythematosus are significantly higher than in other rheumatic diseases and correlate with disease activity.
    Gabay C; Cakir N; Moral F; Roux-Lombard P; Meyer O; Dayer JM; Vischer T; Yazici H; Guerne PA
    J Rheumatol; 1997 Feb; 24(2):303-8. PubMed ID: 9034987
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel mutation in the third extracellular domain of the tumor necrosis factor receptor 1 in a Finnish family with autosomal-dominant recurrent fever.
    Nevala H; Karenko L; Stjernberg S; Raatikainen M; Suomalainen H; Lagerstedt A; Rauta J; McDermott MF; Peterson P; Pettersson T; Ranki A
    Arthritis Rheum; 2002 Apr; 46(4):1061-6. PubMed ID: 11953985
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proinflammatory action of the antiinflammatory drug infliximab in tumor necrosis factor receptor-associated periodic syndrome.
    Nedjai B; Hitman GA; Quillinan N; Coughlan RJ; Church L; McDermott MF; Turner MD
    Arthritis Rheum; 2009 Feb; 60(2):619-25. PubMed ID: 19180495
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevated CD16 expression by monocytes from patients with tumor necrosis factor receptor-associated periodic syndrome.
    Todd I; Radford PM; Ziegler-Heitbrock L; Ghaemmaghami AM; Powell RJ; Tighe PJ
    Arthritis Rheum; 2007 Dec; 56(12):4182-8. PubMed ID: 18050249
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polymorphisms of the TNF gene and the TNF receptor superfamily member 1B gene are associated with susceptibility to ulcerative colitis and Crohn's disease, respectively.
    Sashio H; Tamura K; Ito R; Yamamoto Y; Bamba H; Kosaka T; Fukui S; Sawada K; Fukuda Y; Tamura K; Satomi M; Shimoyama T; Furuyama J
    Immunogenetics; 2002 Mar; 53(12):1020-7. PubMed ID: 11904678
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor necrosis factor receptor gene polymorphisms in Crohn's disease: association with clinical phenotypes.
    Waschke KA; Villani AC; Vermeire S; Dufresne L; Chen TC; Bitton A; Cohen A; Thomson AB; Wild GE
    Am J Gastroenterol; 2005 May; 100(5):1126-33. PubMed ID: 15842589
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus.
    Mahmoud RA; El-Gendi HI; Ahmed HH
    Clin Biochem; 2005 Feb; 38(2):134-41. PubMed ID: 15642275
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monocytic fasciitis: a newly recognized clinical feature of tumor necrosis factor receptor dysfunction.
    Hull KM; Wong K; Wood GM; Chu WS; Kastner DL
    Arthritis Rheum; 2002 Aug; 46(8):2189-94. PubMed ID: 12209524
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical significance of P46L and R92Q substitutions in the tumour necrosis factor superfamily 1A gene.
    Ravet N; Rouaghe S; Dodé C; Bienvenu J; Stirnemann J; Lévy P; Delpech M; Grateau G
    Ann Rheum Dis; 2006 Sep; 65(9):1158-62. PubMed ID: 16569687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neutrophils from patients with TNFRSF1A mutations display resistance to tumor necrosis factor-induced apoptosis: pathogenetic and clinical implications.
    D'Osualdo A; Ferlito F; Prigione I; Obici L; Meini A; Zulian F; Pontillo A; Corona F; Barcellona R; Di Duca M; Santamaria G; Traverso F; Picco P; Baldi M; Plebani A; Ravazzolo R; Ceccherini I; Martini A; Gattorno M
    Arthritis Rheum; 2006 Mar; 54(3):998-1008. PubMed ID: 16508982
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The tumor-necrosis-factor receptor-associated periodic syndrome: new mutations in TNFRSF1A, ancestral origins, genotype-phenotype studies, and evidence for further genetic heterogeneity of periodic fevers.
    Aksentijevich I; Galon J; Soares M; Mansfield E; Hull K; Oh HH; Goldbach-Mansky R; Dean J; Athreya B; Reginato AJ; Henrickson M; Pons-Estel B; O'Shea JJ; Kastner DL
    Am J Hum Genet; 2001 Aug; 69(2):301-14. PubMed ID: 11443543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overlap syndrome between Familial Mediterranean fever and tumor necrosis factor receptor-associated periodic syndrome in a lupus patient.
    Nonaka F; Migita K; Iwasaki K; Shimizu T; Kawakami A; Yasunami M; Eguchi K
    Tohoku J Exp Med; 2014 Jun; 233(2):73-7. PubMed ID: 24835548
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autosomal dominant periodic fever with AA amyloidosis: tumor necrosis factor receptor-associated periodic syndrome (TRAPS) in a Turkish family.
    Dinc A; Erdem H; Rowczenio D; Simsek I; Pay S; Bahce M; Lachmann H
    J Nephrol; 2005; 18(5):626-9. PubMed ID: 16299693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.